2025 Internal Control Evaluation Report

Jingjiang Yong'an Pharmaceutical Co., Ltd. Internal Control Evaluation Report

Jingjiang Yong'an Pharmaceutical Co., Ltd. 2025 Internal Control Evaluation Report

To all shareholders of Jingjiang Yong'an Pharmaceutical Co., Ltd.:

In accordance with the "Basic Norms for Enterprise Internal Control" and its supporting guidelines, as well as other internal control regulatory requirements (collectively referred to as the "Enterprise Internal Control Norms System"), and based on the company's internal control system and evaluation methods, we have conducted an evaluation of the effectiveness of the company's internal control as of December 31, 2025 (the "Internal Control Evaluation Reporting Date"), based on daily supervision and special supervision of internal control.

I. Important Statement

It is the responsibility of the company's Board of Directors to establish, improve, and effectively implement internal control in accordance with the Enterprise Internal Control Norms System, evaluate its effectiveness, and disclose it truthfully in the Internal Control Evaluation Report. The Audit Committee supervises the establishment and implementation of internal control by the Board of Directors. The management is responsible for organizing and leading the daily operation of the company's internal control.

The Board of Directors, the Audit Committee, and the directors and senior management guarantee that the content of this report contains no false records, misleading statements, or significant omissions, and they shall bear individual and joint legal responsibility for the authenticity, accuracy, and completeness of the report's content.